contrast reduction

Figure 1. Generation and use of a dynamic coronary roadmap during percutaneous coronary intervention

Original Contribution

Roadmap Fusion Imaging in Percutaneous Coronary Intervention Reduces Contrast Medium Exposure Irrespective of Investigator’s Experience Level

01/12/2024

Verena Veulemans , MD;

Shazia Afzal , MD;

Ralf Erkens , MD;

Amin Polzin , MD;

Christine Quast , MD;

Raphael Phinicarides , MD;

Nora Berisha , MD;

Kathrin Klein , MD;

Pia Leuders , MD;

Tobias Zeus , MD;

Florian Bonner , MD;

Malte Kelm , MD;

Christian Jung , MD, PhD;

In this study, the authors aimed to determine if Dynamic Coronary Roadmap software is equally effective irrespective of the performing investigator’s experience level.

In this study, the authors aimed...

01/12/2024

Journal of Invasive Cardiology

Letter from the Editor

Use of the DyeVert System in Chronic Total Occlusion Percutaneous Coronary Intervention

08/27/2019

Yale Wang , MD;

Iosif Xenogiannis , MD;

Ivan Chavez , MD;

Mario Gössl , MD, PhD;

Allison Hall , MD;

Anil Poulose , MD;

Peter Tajti , MD;

M. Nicholas Burke , MD;

Michael R. Mooney , MD;

Paul Sorajja , MD;

Emmanouil S. Brilakis , MD, PhD, FACC, FAHA, FESC, FSCAI;

Bavana V. Rangan , BDS, MPH, MD;

Evangelia Vemmou , MD;

Imre Ungi , MD, PhD;

Ilias Nikolakopoulos , MD;

Pamela Morley , RN;

Santiago Garcia , MD;

CTO-PCI often requires administration of large contrast volume. The DyeVert system (Osprey Medical, Inc) is a device that interfaces with standard manifold systems to reduce the amount of contrast used. We compared the procedural outcomes of...

CTO-PCI often requires...

08/27/2019

Journal of Invasive Cardiology

Original Contribution

Contrast Minimization With the New-Generation DyeVert Plus System for Contrast Reduction and Real-Time Monitoring During Coronary and Peripheral Procedures: First Experience

07/25/2017

Arturo Giordano , MD, PhD;

Nicola Corcione , MD;

Paolo Ferraro , MD;

Stefano Messina , MD;

Gennaro Maresca , MD;

Raffaella Avellino , BSc;

Giovanni Napolitano , MD;

Elena Cavarretta , MD, PhD;

Contrast-induced nephropathy remains the main adverse effect of contrast administration. We appraised the DyeVert Plus system inclusive of contrast reduction and real-time monitoring in a consecutive series of coronary or peripheral...

Contrast-induced nephropathy...

07/25/2017

Journal of Invasive Cardiology